BE869406A - Vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c et procede pour sa preparation - Google Patents

Vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c et procede pour sa preparation

Info

Publication number
BE869406A
BE869406A BE189615A BE189615A BE869406A BE 869406 A BE869406 A BE 869406A BE 189615 A BE189615 A BE 189615A BE 189615 A BE189615 A BE 189615A BE 869406 A BE869406 A BE 869406A
Authority
BE
Belgium
Prior art keywords
preparation
high molecular
molecular mass
vaccine against
against group
Prior art date
Application number
BE189615A
Other languages
English (en)
French (fr)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of BE869406A publication Critical patent/BE869406A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BE189615A 1977-08-01 1978-07-31 Vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c et procede pour sa preparation BE869406A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/820,665 US4123520A (en) 1977-08-01 1977-08-01 Method for preparing high molecular weight meningococcal Group C vaccine

Publications (1)

Publication Number Publication Date
BE869406A true BE869406A (fr) 1979-01-31

Family

ID=25231420

Family Applications (1)

Application Number Title Priority Date Filing Date
BE189615A BE869406A (fr) 1977-08-01 1978-07-31 Vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c et procede pour sa preparation

Country Status (17)

Country Link
US (1) US4123520A (fi)
JP (1) JPS5446893A (fi)
AR (1) AR222974A1 (fi)
BE (1) BE869406A (fi)
CA (1) CA1112566A (fi)
DE (1) DE2833545A1 (fi)
DK (1) DK308578A (fi)
EG (1) EG13435A (fi)
FI (1) FI59024C (fi)
FR (1) FR2399252A1 (fi)
GB (1) GB2001530B (fi)
IE (1) IE47149B1 (fi)
IT (1) IT1107462B (fi)
LU (1) LU80063A1 (fi)
NL (1) NL7807419A (fi)
ZA (1) ZA784324B (fi)
ZM (1) ZM6778A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460139A1 (fr) * 1979-06-29 1981-01-23 Pasteur Institut Fraction antigenique glycopeptidique vaccinante a tres grande immunogenicite isolee de cultures de germes pathogenes, procedes d'isolement de cette fraction et vaccins contenant ladite fraction
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
EP0109688A3 (en) * 1982-11-23 1986-12-03 The Wellcome Foundation Limited Improved complexes, processes for obtaining them and formulations containing such complexes
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
EP0145359B1 (en) * 1983-11-21 1991-01-16 The Wellcome Foundation Limited Improved complexes, processes for obtaining them and formulations containing such complexes
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
FR2619122B1 (fr) * 1987-08-03 1990-03-09 Pasteur Institut Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
US4877613A (en) * 1987-08-05 1989-10-31 Biotech Connections, Inc. Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli
US5225194A (en) * 1989-11-13 1993-07-06 Ldc Research Corporation Aqueous diafiltration process for preparing acellular vaccines, against selected bacterial diseases
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
US20040213806A1 (en) * 1998-08-28 2004-10-28 Smithkline Beecham Biologicals, S.A. Salmonella typhi vaccine compositions
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
PT1896065E (pt) 2005-06-27 2011-08-31 Glaxosmithkline Biolog Sa Processo para a preparação de vacinas
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines

Also Published As

Publication number Publication date
IE47149B1 (en) 1983-12-28
FI59024C (fi) 1981-06-10
FI59024B (fi) 1981-02-27
GB2001530B (en) 1982-03-03
AR222974A1 (es) 1981-07-15
IT7850445A0 (it) 1978-07-24
US4123520A (en) 1978-10-31
ZM6778A1 (en) 1980-06-20
EG13435A (en) 1981-06-30
JPS5446893A (en) 1979-04-13
CA1112566A (en) 1981-11-17
FR2399252A1 (fr) 1979-03-02
FR2399252B1 (fi) 1981-07-31
ZA784324B (en) 1980-03-26
IE781541L (en) 1979-02-01
NL7807419A (nl) 1979-02-05
DK308578A (da) 1979-02-02
LU80063A1 (fr) 1979-05-15
FI782204A (fi) 1979-02-02
IT1107462B (it) 1985-11-25
DE2833545A1 (de) 1979-02-15
GB2001530A (en) 1979-02-07

Similar Documents

Publication Publication Date Title
BE869406A (fr) Vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c et procede pour sa preparation
DE2860900D1 (en) Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them
FR2340950A1 (fr) Esters du cefuroxime, leur procede de preparation et leur application en therapeutique
NO177937C (no) Fremgangsmåte for fremstilling av masse
BE858992A (fr) Procede de preparation de vaccins
BE863178A (nl) Blokcopolymeercomposities, werkwijze ter bereiding daarvan en eruit bereide voorwerpen
LU76848A1 (fr) Nouveaux hydroxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application therapeutique
IL55109A (en) 1-acyl-2-cyanoaziridines,process for their preparation and pharmaceutical compositions containing them
FR2476658B1 (fr) Procede perfectionne de preparation d'un polyester de masse moleculaire elevee
FR2289534A1 (fr) Procede de preparation de copolymeres de styrene et d'acrylonitrile
BE828430A (fr) Phenylalcoylamines, leur procede d'obtention et leur application commemedicaments
FR2285145A1 (fr) Composes immunologiques et procede de leur preparation
DE2861361D1 (en) 1-n-acylated-4-o-glycosyl-6-o-glycosyl-1,3-diaminocyclitol derivatives, process for their preparation and pharmaceutical compositions containing them
FR2277063A1 (fr) Procede de preparation du lavandulol et de ses esters
FR2282887A1 (fr) Derives de tetrahydropyridine et de piperidine et procede pour leur preparation
FR2282903A1 (fr) Esters triacyles en positions 9,3'',4'' de l'antibiotique sf-837 m1 et procede de preparation y associe
BE871586A (fr) Vaccin contre haemophilus influenzae et procede pour sa preparation
BE831786A (fr) Vaccin contre la gravidite et procede de sa preparation
DE2861767D1 (en) Cephalosprin derivatives, process for their preparation and pharmaceutical compositions containing them
BE828040A (fr) Nouvel antibiotique, ses derives et procede de preparation
PT68267A (fr) Procede de preparation de derives d'oxadiazole-1,2,4 et leur application en therapeutique
EP0001914A3 (en) Antibacterially active amides, process for their preparation and pharmaceutical compositions containing said amides
BE845513A (fr) Nouvel antibiotique et procede de sa preparation
NO155976C (no) Anordning for fremstilling av mekanisk masse.
ZA784123B (en) Imidazo-isoquinoline-diones,process for preparation and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MERCK & CO. INC.

Effective date: 19870731